Inaugural Imperial Cardiometabolic Symposium Thu and Fri Sept 10th and 11th. |
[[£29 (in person paypal) below]] [[£29 (in person TIDE) link]] [[Zoom booking penalty £69]] [[pdf timetable]]
CPD applied for, code follows. £29 in person subsidised or £69 on zoom. |
Wolfson Education Centre, Hammersmith Hospital or live on zoom |
Day 1: Thursday 10th September [[location MAP]]
9:15 9:45: Coffee and registration
9:45-9:50: Welcome and Introduction Julia Kenkre, (Consultant in Metabolic Medicine, Imperial College Healthcare NHS Trust)
9:50-10:10: The landscape of Cardiometabolic care in the UK Helen Williams ( National Clinical Director for Cardiovascular Disease Prevention at NHS England, and Clinical Care Professional Lead for Long-Term Conditions for the South East London Integrated Care System.
|
Session 1: Obesity (Chairs: Dr Harvinder Chahal, Mr Ahmed R Ahmed) |
||
|
Time
|
Title |
Confirmed speaker
|
|
10:10 - 10:30 |
How we can use weight-loss drugs pharmacotherapy to reduce ASCVD in obesity |
Prof Tricia Tan, Consultant in Endocrinology and Metabolic Medicine, Imperial College Healthcare NHS Trust |
|
10:30 10:50 |
How does obesity lead to its adverse cardiometabolic outcomes?
|
Prof Sir Steve O Rahilly, Director, MRC Metabolic Diseases Unit Professor of Clinical Biochemistry and Medicine, Department of Clinical Biochemistry, University of Cambridge, Wellcome Investigator |
|
10:50 11:00 |
The future obesity medicines |
Ben Jones, Associate Prof and Consultant in Metabolic Medicine |
|
11:00 11:10 |
Abstract presentation and questions (7 mins presentation + 3 mins Q) |
|
|
11:10 11:20 |
Panel discussion: Prof Tan, Prof O Rahilly, Dr Jones |
|
|
BREAK |
||
|
Session 2: Cardiology/Cardiothoracic (Chair: Mr Emad Al-Jalaly )
|
||
|
11:50 |
Lipoprotein (a): an overview of risk, testing and treatment |
Jai Cegla, Consultant in Metabolic Medicine Imperial College Healthcare NHS Trust |
|
12:10 |
Who does best from a CABG and the future of bypass surgery? |
Mr Harry Smith, Cardiothoracic Clinical Fellow, Imperial College Healthcare NHS Trust |
|
12:30 |
The role of inflammation in coronary plaques |
Prof Ramzi Khamis, Consultant Cardiologist Imperial College Healthcare NHS Trust |
|
12:45 |
Abstract presentation and questions (7 mins presentation + 3 mins Q) |
|
|
12:55 |
Panel discussion: Mr Al-Jalaly, Mr Smith, Dr Cegla, Prof Khamis |
|
|
LUNCH |
||
|
Session 3: Cerebrovascular disease (Chairs: Dr Jai Cegla and TBC )
|
||
|
14:15 |
Lipid management in hyperacute stroke and TIA |
Dr Joseph Kwan, Stroke Consultant, Imperial College Healthcare NHS Trust |
|
14:35 |
How should we manage CVD prevention in the frail patient? |
Colin Mitchell, Consultant Geriatrician, Imperial College Healthcare NHS Trust |
|
14:55 |
How to manage hypertension |
Neil Chapman, Consultant in Gen Medicine and Clinical Pharmacology, Lead clinician for the Peart-Rose Clinic |
|
15:25 |
Abstract presentation and questions (7 mins presentation + 3 mins Q) |
|
|
15:35 |
Panel discussion |
|
|
BREAK |
||
|
Session 4: Lipids and cardiovascular risk (Chairs: Julia Kenkre and Ben Jones)
|
||
|
16:00
|
Hypercholesterolaemia and mixed dyslipidaemia: deciphering it all |
Mubin Choudhury, Consultant in Metabolic Medicine, Imperial College Healthcare NHS Trust |
|
16:20 |
Managing cardiovascular risk post MI |
Dr Iqbal Malik, Consultant Cardiologist, Imperial College Healthcare NHS Trust |
|
16:40 |
What will lipid management look like in 5 years time? |
Prof Ray, Professor of Public Health and Honorary Cardiologist at Imperial College London |
|
17:10 |
Abstract presentation and questions (7 mins presentation + 3 mins Q) |
|
|
17:20 |
Panel discussion |
|
|
CLOSE DAY 1 |
||
Day 2: FRIDAY 11th SEPTEMBER 2026
8:30 8:50 Coffee and registration
8:50 9:00:Shaping the Next Decade: What the 10‑Year Health Plan Means for Cardiometabolic Care Lord Ara Darzi (remotely), Chair of Surgery at Imperial College London, the Royal Marsden Hospital and the Institute of Cancer Research, Director of the Institute of Global Health Innovation at Imperial College London and Chair of Imperial College Health Partners, Honorary Consultant Surgeon at Imperial College Hospital NHS Trust
9:00 - 9:25: The utility of grouping cardiometabolic conditions for research, clinical practice and health systems Prof Jonathan Valabjhi, Clinical Chair in Medicine, Honorary Consultant Diabetologist at Chelsea and Westminster Hospital
|
Time |
Title |
Speaker |
|
|
Session 5: Vascular disease and imaging Chairs TBC |
|||
|
9:25 9:45 |
The future management of small vessel disease |
Prof Alistair Webb, Clinical Associate Professor in Stroke Medicine / NHS Honorary Consultant Neurologist, Imperial College Healthcare NHS Trust |
|
|
9:45 10:05 |
Advances in peripheral vascular disease |
Mr Joe Shaloub, Consultant Vascular Surgeon, Imperial College Healthcare NHS Trust |
|
|
10:05-10:25 |
Risk and Rupture: Using imaging to define cardiovascular risk and assess plaque vulnerability |
Dr Ben Ariff, Consultant radiologist, Imperial College Healthcare NHS Trust |
|
|
10:25 10:35 |
Abstract presentation and questions (7 mins presentation + 3 mins Q) |
||
|
10:35 10:45 |
Panel discussion |
||
|
BREAK |
|||
|
Session 6: Renal: Chairs Dr James Tomlinson and Dr Pari Avari |
|||
|
11:15 -11:35 |
Managing obesity in CKD |
Dr Andrew Frankel, Consultant nephrologist, Imperial College Healthcare NHS Trust |
|
|
11:35 11:55 |
Why renal transplant patients have increased CV risk and what we can do to manage it |
Dr Michelle Willicombe, Consultant nephrologist, Imperial College Healthcare NHS Trust |
|
|
11:55 12:10 |
Lipids in adults with diabetic kidney disease |
Dr Sagen Zac-Varghese, Consultant in Diabetes and Endocrinology, East and North Hertfordshire NHS Trust |
|
|
12:10 12:20 |
Abstract presentation and questions (7 mins presentation + 3 mins Q) |
||
|
12:20 12:30 |
Panel discussion |
||
|
LUNCH |
|||
|
Session 7: MASLD: Chairs Dr Chioma Izzi-Engbeaya and Prof Mark Thursz |
|||
|
13:40: 14:00 |
Spotting Liver Fibrosis Early: Targeted Case‑Finding in High‑Risk Groups
|
TBC |
|
|
14:00 14:20 |
How do we reduce CV risk in patients with MASLD? |
Prof Chris Byrne. Professor of Endocrinology and Metabolism Southampton |
|
|
14:20 14:35 |
The Future of MASLD: Breakthroughs Set to Transform Care in the Next Five Years .
|
Dr Pinelopi Manousou, Consultant hepatologist, Imperial College Healthcare NHS Trust |
|
|
14:35 14:45 |
Abstract presentation and questions (7 mins presentation + 3 mins Q) |
||
|
14:45 -14:55 |
Panel discussion |
||
|
BREAK |
|||
|
Session 8: Diabetes and primary care (Chairs:TBC) |
|||
|
15:25 15:45 |
Metabolic dysfunction and the use of adjunct medications in Type 1 diabetes |
Prof Vicky Salem , RD Lawrence Professor of Diabetic Medicine, Kings College London
|
|
|
15:45 16:05 |
CV risk in Young onset T2 |
Dr Shivani Misra, Associate Prof and Consultant in Metabolic Medicine ICHNT |
|
|
16:05-16:15 |
Managing CV Risk in the community |
Dr Deep Shah, General practitioner |
|
|
16:15 16:25 |
Abstract presentation and questions (7 mins presentation + 3 mins Q) |
||
|
16:25 16:35 |
Panel discussion |
||
|
Session 9 (16:35 17:20 minutes): Clinical cases How would you manage this case? Chaired by Prof Meeran with lipidologist Dr Jai Cegla, Renal Physician Dr James Tomlinson Liver TBC Cardio TBC Diabetes - |
|||
|
|
|||
|
CLOSE |
|||